摘要:Pancreatic cancer,mostly pancreatic ductal adenocarcinoma(PDAC),is a leading cause of cancer-related death in the US,with a dismal median survival of 6 months.Thus,there is an urgent unmet need to identify ways to diagnose and to treat this deadly cancer.Although a number of genetic changes have been identified in pancreatic cancer,their mechanisms of action in tumor development,progression and metastasis are not completely understood.Hedgehog signaling,which plays a major role in embryonic development and stem cell regulation,is known to be activated in pancreatic cancer;however,specific inhibitors targeting the smoothened molecule failed to improve the condition of pancreatic cancer patients in clinical trials.Furthermore,results regarding the role of Hh signaling in pancreatic cancer are controversial with some reporting tumor promoting activities whereas others tumor suppressive actions.In this review,we will summarize what we know about hedgehog signaling in pancreatic cancer,and try to explain the contradicting roles of hedgehog signaling as well as the reason(s) behind the failed clinical trials.In addition to the canonical hedgehog signaling,we will also discuss several non-canonical hedgehog signaling mechanisms.
注:因版权方要求,不能公开全文,如需全文,请咨询杂志社。
南京医科大学学报·自然科学版杂志, 月刊,本刊重视学术导向,坚持科学性、学术性、先进性、创新性,刊载内容涉及的栏目:基础研究、基础医学、综述、病例报告、影像医学、述评、公共卫生与预防医学研究、影像医学研究、病毒肺炎研究、公共卫生与预防医学、预防医学、口腔医学研究、技术方法等。于1956年经新闻总署批准的正规刊物。